Jun Qi

39PUBLICATIONS
356CO-AUTHORS
Predictive and prognostic markersBiomedical instrumentationMedical devicesHaematological tumoursPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Oct 20, 2026
Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300.

|May 28, 2026
Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma.

|Apr 15, 2026
Structural Basis for BD1-Preferring 2,4-Disubstituted Pyrimidine BRDT Inhibitors.

|Mar 26, 2026
Dominant clones leverage developmental epigenomic states to drive ependymoma.

Alisha S Kardian, Hua Sun, Siri Ippagunta

|Jan 20, 2026
Proteasome Cap Targeting Chimeras for Ubiquitination-Independent Targeted Protein Degradation.

Chen Song, Qi Liu, Tingjian Wang

|Dec 07, 2025
EP300 deficiency leads to chronic replication stress mediated by defective replication fork protection.

Angelica Barreto-Galvez, Mrunmai Niljikar, Julia Elizabeth Gagliardi

Pageof 7

Frequent Collaborators

8 joint publications

Adam Durbin

3 joint publications

Tingjian Wang

3 joint publications

Jay Bradner

3 joint publications

Paul M C Park